The Schall Law Firm Files Class Action Lawsuit Against Viatris Inc.
Los Angeles, CA – April 14, 2025
In a recent development, The Schall Law Firm, a renowned national shareholder rights litigation firm, has announced the filing of a class action lawsuit against Viatris Inc. (Viatris or the Company) (NASDAQ: VTRS) for alleged violations of ยงยง10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission (SEC).
Class Action Details
The lawsuit alleges that Viatris and certain executives made false and misleading statements regarding the Company’s business, operational, and financial metrics. Specifically, the complaint asserts that the defendants failed to disclose that the Company’s financial results were negatively impacted by various factors, including supply chain disruptions, regulatory issues, and competitive pressures.
Class Period and Eligibility
The class action covers investors who purchased or acquired Viatris securities during the period from August 8, 2024, to February 26, 2025, inclusive (the “Class Period”).
Important Deadline
Investors interested in participating in the class action are encouraged to contact The Schall Law Firm before June 3, 2025.
Impact on Individual Investors
If the allegations in the lawsuit are proven, Viatris investors who purchased the Company’s securities during the Class Period may be entitled to recover their losses, including damages and interest. The exact amount of damages will depend on the outcome of the case.
Global Implications
The class action lawsuit against Viatris has significant implications for the healthcare industry and investors alike. It underscores the importance of accurate and transparent financial reporting, as well as the role of shareholder rights litigation in holding companies accountable for their actions.
Additional Sources
- BusinessWire: The Schall Law Firm Files Class Action Lawsuit Against Viatris Inc.
- SEC.gov: SEC Charges Viatris Inc. and Certain Executives with Securities Fraud
- Reuters: Viatris accused of securities fraud in class action lawsuit
These sources provide further details on the allegations against Viatris and the potential implications for the healthcare industry and investors.
Conclusion
The Schall Law Firm’s class action lawsuit against Viatris highlights the importance of transparency and accuracy in financial reporting. As the case progresses, investors who purchased Viatris securities during the Class Period will be closely watching the developments. Regardless of the outcome, the lawsuit serves as a reminder of the role of shareholder rights litigation in holding companies accountable for their actions.
Stay informed and protect your investments. For more information, contact The Schall Law Firm.
